Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Axios
Axios
Business
Dan Primack

Moderna closes in on massive biotech IPO

Credit: KTS Design/Getty Images

Moderna Therapeutics, a Massachusetts startup that wants to help patients develop drugs within their own bodies via injections of synthetic mRNA, expects to raise around $618 million in its IPO on Thursday night, Reuters reports.

Why it matters: This would the largest IPO ever for a development-stage biotech company, and its $8 billion initial market cap would be the year's third-largest for VC-backed companies, according to Renaissance Capital (behind only Dropbox and Spotify).

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.